Butterfly Network, Inc. (NYSE: BFLY), a digital health company pioneering accessible medical imaging, announced it will release its third quarter 2025 financial results on October 31, 2025, before the market opens. The company will host a conference call and live webcast at 8:00 a.m. ET on the same day to discuss its financial performance and operational progress. Joseph DeVivo, President, Chief Executive Officer, and Chairman of the Board, will lead the call alongside Megan Carlson, Interim Chief Financial Officer. The event will be available to the public via a live webcast on Butterfly’s Investor Relations website under the Events & Presentations section. Participants can join the call by telephone using the following numbers: United States (Toll-Free): +1 833-470-1428 United States (Local): +1 646-844-6383 Global Dial-In Numbers: https://www.netroadshow.com/conferencing/global-numbers?confId=87589 Access Code: 849303 The webcast will be available in listen-only mode. After the live session, a replay will be archived on the Investor Relations page. A telephone replay will also be accessible until November 7, 2025, using the following numbers: United States (Local): +1 929 458 6194 United States (Toll-Free): +1 866 813 9403 Access Code: 583803 Butterfly Network, Inc. (NYSE: BFLY) is transforming healthcare through its proprietary Ultrasound-on-Chip™ technology and advanced software solutions. In 2018, the company launched the Butterfly iQ, the world’s first handheld, single-probe, whole-body ultrasound device. This was followed by the iQ+ in 2020 and the iQ3 in 2024, each featuring enhanced processing power and performance driven by advancements in semiconductor technology aligned with Moore’s Law. The iQ3 was honored as Best Medical Technology at the 2024 Prix Galien USA Awards, one of the most prestigious recognitions in healthcare innovation. Butterfly’s platform integrates intelligent software, artificial intelligence, cloud-based services, and educational tools to make medical imaging more affordable and accessible. Clinical studies have shown that its handheld devices, when paired with Compass™ enterprise workflow software, help healthcare systems streamline operations, reduce costs, and improve provider outcomes. The company’s cloud-enabled platform supports mobile care delivery, enabling diagnostics and treatment in remote and underserved areas. Butterfly devices are currently available to trained healthcare professionals across Africa, Asia, Australia, Europe, the Middle East, North America, and South America. The company’s Global Health Program aims to expand access to life-saving imaging in low-resource settings. For more information, visit: https://www.butterflynetwork.com/global-health.